This is the authors' abstract. We don't add key points for this paper.
In their article regarding the use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions,1 Hasteh et al made an error in their calculation of the sensitivity and specificity for desmin, shown in Table 2 of their publication. The sensitivity of desmin should be reported as 6% (3/52 × 100%) instead of 84% and the specificity should be reported as 16% (10/64 × 100%) rather than 94%. Thus, desmin demonstrates limited sensitivity in the detection of mesothelioma, a finding acknowledged in Table 3 of the original article and in the authors' discussion, in which they correctly point out that the combination of a negative desmin and positive epithelial membrane antigen (EMA) correctly identified 94% of the malignant mesothelioma cases. If desmin was a sensitive marker for mesothelioma detection, its expression would be positive and the combined negative desmin/positive EMA profile would not be useful. A complete understanding and careful computations of sensitivity, specificity, and predictive values assume increased importance as more investigators evaluate additional immunocytochemistry reagents and techniques to improve the distinction of malignant mesothelioma from reactive mesothelial cell changes in cytologic specimens.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Stanley J. Geyer (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: